Feedback / Questions
ebselen (SPI-1005) - Sound Pharma
https://www.businesswire.com/news/home/20251201807651/en/Sound-Pharmaceuticals-Receives-FDA-Breakthrough-Therapy-Designation-for-SPI-1005-to-Treat-Menieres-Disease
Dec 1, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next